| Date | Name/CAS No. | Suppliers/Manufactures | Check | ||
|---|---|---|---|---|---|
| 04-17 15:00 | BHQ1-COOH 1190431-95-8 |
||||
| 04-17 14:52 | 3,9-Bis(2,4-dicumylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5] 154862-43-8 |
||||
| 04-17 14:50 | IRGANOX 1330 1709-70-2 |
||||
| 04-17 14:50 | Octyl-3,5-di-tert-butyl-4-hydroxy-hydrocinnamate 125643-61-0 |
||||
| 04-17 14:48 | Antioxidant 245 36443-68-2 |
||||
| 04-17 14:48 | P-SCN-Bn-TCMC 282097-63-6 |
||||
| 04-17 14:45 | P-SCN-BN-DOTA 3030178-92-5 |
||||
| 04-17 14:45 | Urolithin A 1143-70-0 |
||||
| 04-17 14:43 | P-SCN-BN-DOTA 1020407-41-3 |
||||
| 04-17 14:38 | AT-168 31570-04-4 |
||||
| 04-17 14:14 | 4-Chloro-3-(trifluoromethyl)benzenesulfonylchloride 32333-53-2 |
||||
| 04-17 11:29 | Astragaloside III 84687-42-3 |
||||
| 04-17 10:19 | Chloroanthraquinone 82-44-0 |
||||
| 04-17 09:47 | DOTA-SH 865470-67-3 |
||||
| 04-17 09:34 | DOTA-NHS-ester 170908-81-3 |
||||
| 04-17 09:31 | DOTA-p-NCS-Bn 127985-74-4 |
||||
| 04-17 09:27 | DOTA-p-NH2-Bn 181065-46-3 |
||||
| 04-16 16:13 | 1H,5H-Bis[1,2,5]oxadiazolo[3,4-b:3',4'-e]pyrazine 132029-07-3 |
||||
| 04-16 16:12 | 16-hydroxy-hexadecylamine 50602-69-2 |
||||
| 04-16 15:50 | DOTA-p-NO2-Bn 116052-88-1 |